Cargando…
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis
Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass. Since red cell volume determination is no longer readily available, in clinical practice, polycythemia and erythro...
Autores principales: | Gordeuk, Victor R., Key, Nigel S., Prchal, Josef T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442963/ https://www.ncbi.nlm.nih.gov/pubmed/30872370 http://dx.doi.org/10.3324/haematol.2018.210732 |
Ejemplares similares
-
Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked Erythrocytosis
por: Machhi, Rushad, et al.
Publicado: (2022) -
JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit)
por: Zito, Luca, et al.
Publicado: (2011) -
Genetic Background of Congenital Erythrocytosis
por: McMullin, Mary Frances
Publicado: (2021) -
PB2201: ASSOCIATION OF HIGH PLATELETCRIT WITH THROMBOTIC RISK IN POLYCYTHEMIA VERA DEPENDS ON HEMATOCRIT AND LEUKOCYTE COUNT
por: Krecak, Ivan, et al.
Publicado: (2023) -
SURPRISING ERYTHROCYTOSIS RESOLUTION AFTER MYOMECTOMY: MYOMATOUS ERYTHROCYTOSIS SYNDROME
por: Couillandre, Pauline, et al.
Publicado: (2023)